Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments

v3.5.0.2
Financial Instruments
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Financial Instruments
Financial Instruments
The composition of financial instruments is as follows:
 
June 30, 2016
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
Gains
 
Losses
 
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
10,311

 
$

 
$

 
$
10,311

Government debt securities
2,000

 

 

 
2,000

Corporate debt securities
26,889

 
10

 

 
26,899

 
39,200

 
10

 

 
39,210

Less amounts included in cash and cash equivalents
(10,311
)
 

 

 
(10,311
)
 
$
28,889

 
$
10

 
$

 
$
28,899

 
Fair Value at June 30, 2016
 
(in thousands)
Liabilities
 
Contingent Consideration
$
265

Total
$
265

 
December 31, 2015
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
Gains
 
Losses
 
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
17,144

 
$

 
$

 
$
17,144

Government debt securities
17,303

 

 
(30
)
 
17,273

Corporate debt securities
45,353

 

 
(84
)
 
45,269

 
79,800

 

 
(114
)
 
79,686

Less amounts included in cash and cash equivalents
(17,144
)
 

 

 
(17,144
)
 
$
62,656

 
$

 
$
(114
)
 
$
62,542


 
Fair Value at December 31, 2015
 
(in thousands)
Liabilities
 
Contingent Consideration
$
395

Total
$
395


At June 30, 2016, the Company held 5 government and corporate debt securities with an aggregate fair value of $7.7 million that were in an unrealized loss position for less than 12 months. No securities have been in unrealized loss positions for greater than 12 months. Gross unrealized losses were immaterial at June 30, 2016, and represented temporary impairments on government agency and corporate debt securities related to multiple issuers, and were primarily caused by fluctuations in U.S. interest rates. The Company evaluates securities for other-than-temporary impairment on a quarterly basis. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include the length of time and extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the issuer; including changes in the financial condition of the security’s underlying collateral; any downgrades of the security by a rating agency; nonpayment of scheduled interest, or the reduction or elimination of dividends; as well as our intent and ability to hold the security in order to allow for an anticipated recovery in fair value.
All of the Company’s long-term available-for-sale securities were due between 1 and 2 years as of June 30, 2016.
The fair values of the Company’s financial instruments are the amounts that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and are recorded using a hierarchal disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs are used when little or no market data is available.
The Company classifies its financial instruments within Level 1 or Level 2 of the fair value hierarchy on the basis of valuations using quoted market prices or alternate pricing sources and models utilizing market observable inputs, respectively. The Company’s money market funds were valued based on quoted prices for the specific securities in an active market and were therefore classified as Level 1. The government and corporate debt securities have been valued on the basis of valuations provided by third-party pricing services, as derived from such services’ pricing models. The pricing services may use a consensus price which is a weighted average price based on multiple sources or mathematical calculations to determine the valuation for a security, and have been classified as Level 2. The Company reviews Level 2 inputs and fair value for reasonableness and the values may be further validated by comparison to independent pricing sources. In addition, the Company reviews third-party pricing provider models, key inputs and assumptions and understands the pricing processes at its third-party providers in determining the overall reasonableness of the fair value of its Level 2 financial instruments. As of June 30, 2016, the Company has not made any adjustments to the prices obtained from its third party pricing providers. The contingent liability is classified as Level 3 as of June 30, 2016 and December 31, 2015 and is valued using an internal rate of return model. The assumptions used in preparing the internal rate of return model include estimates for future revenues related to Physpeed products and services and a discount factor of 0.45 at June 30, 2016 and 0.41 at December 31, 2015. The assumptions used in preparing the internal rate of return model include estimates for outcome if milestone goals are achieved, the probability of achieving each outcome and discount rates. Significant changes in any of the unobservable inputs used in the fair value measurement of contingent consideration in isolation could result in a significantly lower or higher fair value. A change in estimated future revenues would be accompanied by a directionally similar change in fair value.
The following table presents a summary of the Company’s financial instruments that are measured on a recurring basis:
 
 
 
Fair Value Measurements at June 30, 2016
 
Balance at
June 30, 2016
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
10,311

 
$
10,311

 
$

 
$

Government debt securities
2,000

 

 
2,000

 

Corporate debt securities
26,899

 

 
26,899

 

 
$
39,210

 
$
10,311

 
$
28,899

 
$

Liabilities
 
 
 
 
 
 
 
Contingent consideration
$
265

 
$

 
$

 
$
265

 
$
265

 
$

 
$

 
$
265

 
 
 
Fair Value Measurements at December 31, 2015
 
Balance at December 31, 2015
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Money market funds
$
17,144

 
$
17,144

 
$

 
$

Government debt securities
17,273

 

 
17,273

 

Corporate debt securities
45,269

 

 
45,269

 

 
$
79,686

 
$
17,144

 
$
62,542

 
$

Liabilities
 
 
 
 
 
 
 
Contingent consideration
$
395

 
$

 
$

 
$
395

 
$
395

 
$

 
$

 
$
395


The following summarizes the activity in Level 3 financial instruments:
 
Six Months Ended June 30, 2016
 
2016
 
2015
 
(in thousands)
Contingent Consideration (1)
 
 
 
Beginning balance
$
395

 
$
265

Physpeed earn-out payment
(240
)
 

Loss (gain) recognized in earnings (2)
110

 
(132
)
Ending balance
$
265

 
$
133

Net (loss) gain for the period included in earnings attributable to contingent consideration held at the end of the period
$
(110
)
 
$
132

____________________________
(1)
In connection with the acquisition of Physpeed, the Company recorded contingent consideration based upon the expected achievement of 2015 and 2016 revenue milestones. Changes to the fair value of contingent consideration due to changes in assumptions used in preparing the valuation model are recorded in selling, general and administrative expense in the unaudited consolidated statements of operations.
(2)
Changes to the estimated fair value of contingent consideration for the six months ended June 30, 2016 were primarily due to updates to present value discount factors. Changes to the estimated fair value of contingent consideration for the six months ended June 30, 2015 were primarily due to revisions to the Company's expectations of earn-out achievement.
There were no transfers between Level 1, Level 2 or Level 3 financial instruments in